Navigation Links
Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
Date:11/16/2007

ticipating in assessing bavituximab have extensive experience in conducting mid and late stage cancer studies that adhere to FDA and international standards, and we look forward to working with them to ensure the timely conduct of this important Phase II trial."

Tumor response in this new study will be evaluated using Response Evaluation Criteria in Solid Tumors (RECIST) parameters. The trial is being conducted according to International Conference on Harmonization (ICH) and Good Clinical Practices (GCP) standards.

According to the World Health Organization, metastatic breast cancer is the most commonly diagnosed cancer in women, and is second only to lung cancer as a leading cause of female cancer deaths. The National Cancer Institute estimates that 178,480 U.S. women will be diagnosed with cancer of the breast in 2007 and 40,460 women will die of the disease.

Bavituximab is a monoclonal antibody that binds to a phospholipid called phosphatidylserine that is usually located inside normal cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab is believed to help mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. In a Phase lb trial in advanced cancer patients, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. A protocol for a Phase II trial of bavituximab in combination with the chemotherapy drugs paclitaxel and carboplatin in patients with metastatic breast cancer is currently undergoing regulatory review in India. A protocol for a Phase II trial of bavituximab in combination with the chemotherapy drugs paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) is also under regulatory rev
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... Recently, iFitDress.com, one of the most famous dress suppliers ... brown evening dresses for worldwide clients. In ... prices, up to 50% off. , All its ... carefully made according to most fashionable styles. In addition ... pretty accessories: wedding shoes, dancing shoes, sandals, boots and ...
(Date:7/13/2014)... best treatment and variations in the quality of care ... cancer patients still varies widely between regions within Europe, ... European adults to date, published in The Lancet ... survival for most cancers of the blood has increased ... approval of new targeted drugs in the early 2000s ...
(Date:7/13/2014)... identifies a novel genetic and molecular pathway ... opening up potential new therapeutic strategies for an ... is a chronic inflammatory disorder of the esophagus. ... certain foods and an over-accumulation in the esophagus ... the body,s immune system). EoE can cause a ...
(Date:7/13/2014)... 2014 Victorian Hotel has recently announced ... rental of bikes for its "Cycle the City" program, ... to tour the area using a rental bicycle, available ... love to call Vancouver home, as it is a ... and picturesque journeys through the countryside. Vancouver hotel rooms ...
(Date:7/13/2014)... 2014 Advanced boilers are preferred ... amount of fossil fuels, produce high-capacity power, emit ... increased global warming and climate change concerns, many ... harmful gas emissions and pollutants coming from fossilfuel-based ... the global advance boilers market., The global power ...
Breaking Medicine News(10 mins):Health News:2014 Brown Evening Dresses Added To iFitDress.com 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 2Health News:North America Advanced Boilers Market is Expected to Reach $518.7billion by 2019 - New Report by MicroMarket Monitor 3
... basket of fruit, it doesn,t seem very difficult to recognize ... thanks to "feature binding" a process by which our brain ... gives us a complete and unified picture of it. For ... gets to work, connecting (or binding) information about each fruit,s ...
... Raging wildfires that engulfed Southern California earlier this decade ... also caused significant health problems for many who lived ... hospital and emergency department admissions directly before, during and ... increase in treatment for those with asthma, bronchitis and ...
... infectious diseases jumping from animals to humans? Why do we ... Some answers, and possible solutions, can be found in the ... 17 in the Yearbook of Physical Anthropology . , ... in the world are coming from wildlife. And most of ...
... low risk of complication is associated with a routine ... endovascular coiling has started to recur, a study led ... , The multi-site, retrospective study, published in the November ... of 0.43 percent in 2,243 patients who had undergone ...
... that in order to perform well, they can,t just ... decision-making are just as essential. Two researchers from the ... discovered how to train the brain of athletes to ... and postdoctoral student David Tinjust, put a dozen soccer, ...
... of six months and six years old, close to 90 ... the most common issues are night terrors, teeth-grinding and bed-wetting. ... passes. But at least 30 percent of children in this ... because they can,t fall into slumber or they can,t stay ...
Cached Medicine News:Health News:Bound by attention: Bringing rats and humans together 2Health News:Hospital visits for respiratory illnesses spiked during Southern California wildfires 2Health News:Primate disease field guide covers critical gap in global health 2Health News:Routine testing after aneurysm coiling carries low risk 2Health News:Routine testing after aneurysm coiling carries low risk 3Health News:New tool trains athlete brains to react 53 percent faster 2Health News:26 percent of sleepless children become overweight 2
(Date:7/10/2014)... Quebec , July 10, 2014  Valeant Pharmaceuticals ... VRX) today announced it has completed the sale to ... and Dysport owned or held by Valeant for $1.4 ... with Nestle S.A, which recently completed its acquisition of ... the divestiture of our products to a company that ...
(Date:7/10/2014)... , July 10, 2014   LabStyle Innovations ... Solution, today announced the appointment of Professor ... of its Board of Directors. Prof. ... business experience to LabStyle as an entrepreneur, venture ... and corporate governance expert. He currently serves on ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
Breaking Medicine Technology:LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
... is pleased to announce the new AortaScan(TM) AMI 9700 ... of abdominal aortic aneurysms (AAA). Designed with Emergency ... AortaScan(TM) AMI 9700 uses 3D ultrasound to quickly and ... the need for a sonographer. This crucial diameter ...
... Reportlinker.com announces that a new market research report is ... Supplies Market , http://www.reportlinker.com/p0135788/US-Disposable-Medical-Supplies-Market.html ... rise 4.1% annually through 2013 , Demand for disposable ... percent annually to more than $79 billion in 2013. An ...
Cached Medicine Technology:Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments 2Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments 3Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments 4Reportlinker Adds US Disposable Medical Supplies Market Report 2Reportlinker Adds US Disposable Medical Supplies Market Report 3Reportlinker Adds US Disposable Medical Supplies Market Report 4Reportlinker Adds US Disposable Medical Supplies Market Report 5Reportlinker Adds US Disposable Medical Supplies Market Report 6Reportlinker Adds US Disposable Medical Supplies Market Report 7Reportlinker Adds US Disposable Medical Supplies Market Report 8Reportlinker Adds US Disposable Medical Supplies Market Report 9Reportlinker Adds US Disposable Medical Supplies Market Report 10Reportlinker Adds US Disposable Medical Supplies Market Report 11Reportlinker Adds US Disposable Medical Supplies Market Report 12
18 gauge straight. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation....
Set consist of two 27 gauge, stainless steel probes with blunt tips. Probes are 11.5 cm (4.5 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto th...
Straight, soft flexible tip allows atraumatic entry through a retinal tear or hole for aspiration of subretinal fluids. 20 gauge x 25 mm cannula attached to 25 gauge x 6 mm tip with 13 mm flexible tu...
20 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
Medicine Products: